- NewsCNBC.com•2 days ago
Suze Orman shares the biggest money mistake almost everyone makes
No matter what your goal is — a bigger house, early retirement or getting out of debt — everyone wants to boost their income. But do you know what to do when you finally earn enough money to reach those financial milestones? Probably not. That's according to Suze Orman, financial expert and former CNBC television host, who told the audience at the eMerge Americas conference in Miami, Fla., "I'm worried about you. Every single one of you I'm worried about, because you're focusing on success, which is great, but you're not focusing on making more out of less." The biggest mistake Orman sees people everywhere make is that they're not taking an active role in handling their own money. Everyone is
BusinessThe Street•21 hours agoThis Is How the Ongoing Death of Sears Could Force J.C. Penney Into a Drastic Decision
J.C. Penney (JCP) could be caught in the downdraft of its dying rival on the other end of the mall, and forced to close even more stores. "Our analysis suggests that Sears ( SHLD) revenue donation is providing a moderate near-term boost [to J.C. Penney] to sales and earnings ($54 million in revenue, and $0.03 in EPS). However, we believe that any further Sears store closings may increase the likelihood that J.C. Penney will have to accelerate the closure of lower-tier mall locations, adding meaningful medium-term revenue and EPS risk of about $150- 200 million and $0.09," wrote Credit Suisse analyst Christian Buss on Friday. Buss rates J.C. Penney shares at an under-perform. The analysis is
- BusinessThe Street•23 hours ago
These products from Medical Marijuana are legal in all 50 states
Medical Marijuana Inc. (MJNA) , a $321 million market cap company that claims to be the first publicly traded medicinal cannabis firm, is no different. For the quarter ended March 31, San Diego-based Medical Marijuana saw revenue jump about 135% to $3.6 million from $1.5 million in the same quarter of the previous year. Over-the-counter-traded Medical Marijuana is beginning to face one of its largest obstacles: its debt load, which clocks in at $13 million for the quarter ended March 31, according to the company's earnings release on June 5. During the first nine months of 2016 Medical Marijuana spent about $6.7 million to reduce its debt load, up from $3 million devoted to paying down debt in 2015 and $990,000 in 2014.
